Skip to main content
Clinical Trials/JPRN-UMIN000042801
JPRN-UMIN000042801
Completed
未知

Epidemiological Study to Evaluate the Prevalence and Progression of Diabetic Macular Ischemia in Patients with Diabetic Retinopathy Treated with Panretinal Photocoagulation - EYE DMI

Boehringer Ingelheim International GmbH0 sites539 target enrollmentJanuary 12, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Boehringer Ingelheim International GmbH
Enrollment
539
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 12, 2021
End Date
October 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Exclusion criteria (Part A and B): Patients currently participating in an interventional trial with an ophthalmologic experimental therapy Exclusion criteria (Part B only): Severe DRIL, i.e., affecting 50% or more of the central one\-mm\-wide zone centered on the fovea (foveal DRIL), as defined by Sun et al. \[R19\-4048]\* Any concurrent macular abnormality other than DMI and DME that, in the opinion of the investigator, would interfere with the assessment of DMI and DME (e.g., significant macular epiretinal membrane, neovascular age\-related macular degeneration, and macular hemorrhage)\*

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR)Mutation Status in Non-Small Cell Lung Cancer (NSCLC) in India.Health Condition 1: null- Non Small Cell Lung Cancer
CTRI/2013/10/004077Roche Products India Pvt Ltd250
Recruiting
Not Applicable
RETROSPECTIVE OBSERVATIONAL STUDY OF BRAF AND PIK3CA MUTATION IN INDIAN PATIENTS WITH COLORECTAL CANCERâ??Health Condition 1: null- Colorectal CancerHealth Condition 2: C189- Malignant neoplasm of colon, unspecified
CTRI/2016/06/006989Tata Memorial Hospital
Recruiting
Not Applicable
Epidemiological Study to Determine the Prevalence of ctDNA Positivity in Participants With Stage II (High Risk) or Stage III CRC After Surgery With Curative (R0) Intent and Subsequent Adjuvant Chemotherapy With Monitoring of ctDNA During Clinical Follow-upColorectal Cancer Stage IIColorectal Cancer Stage III
DRKS00025104BioNTech SE1,500
Completed
Not Applicable
A study to find out total number of Diabetic patients and Factors influencing it in our Kanyakumari district , its severity , associated health problems and how our behavioral modifications controls the same.
CTRI/2019/09/021122RojaVanam Trust256
Recruiting
Not Applicable
Prospective study for determining the prevalence of causes of ABO blood group discrepancies and to establish a clinical classification in a tertiary care transfusion centeHealth Condition 1: Z671- Type A bloodHealth Condition 2: Z673- Type AB bloodHealth Condition 3: Z672- Type B bloodHealth Condition 4: Z674- Type O blood
CTRI/2023/06/053798MAHE Thesis Grant